Article
Sponsored Content
Disruption without interruption: Transitioning Rare Disease HUB & NCP Programs
Author(s):
Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Related Content
